SCOTTSDALE, Arizona, October 25, 2013 – Provista Diagnostics, Inc., a leading molecular diagnostics company focused on developing and commercializing proprietary diagnostic, prognostic and predictive tests for cancers affecting women, has licensed a series of biomarker technologies developed by researchers at the Biodesign Institute of Arizona State University. Provista will evaluate the technologies for use in the early detection of breast cancer, ovarian cancer and HPV.
Tag Archives: Provista
Provista to go public with breast, lung cancer testing technology
Phoenix Business Journal, Friday, December 30, 2011
by Linda Obele, Contributing Writer
The Great Recession seems to have been more of a nuisance than a hindrance to Provista Life Sciences .Continue reading